Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
131M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
52.1M
-
Shares change
-
-5.99M
-
Total reported value, excl. options
-
$677M
-
Value change
-
-$80.7M
-
Put/Call ratio
-
1.43
-
Number of buys
-
91
-
Number of sells
-
-62
-
Price
-
$12.99
Significant Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q1 2021
198 filings reported holding AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value as of Q1 2021.
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.1M shares
of 131M outstanding shares and own 39.89% of the company stock.
Largest 10 shareholders include FMR LLC (9.31M shares), ORBIMED ADVISORS LLC (6.07M shares), NEA Management Company, LLC (5.17M shares), PICTET ASSET MANAGEMENT LTD (3.81M shares), Avidity Partners Management LP (1.78M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1.75M shares), CITADEL ADVISORS LLC (1.43M shares), BAKER BROS. ADVISORS LP (1.41M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.35M shares), and BlackRock Inc. (1.1M shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.